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Abstract
The Aﬀordable Care Act is one of the biggest changes in the American healthcare
system in the 21st century. One element of the ACA is medicaid expansion, which
opened up federal funding for states to cover any individual earning below 138% of the
federal poverty line. 21 states expanded medicaid in 2014 while 12 haven’t expanded.
This paper utilizes the disparity for a natural experiment to determine the eﬃcacy of the
program. Outcome variables of interest include measurements of individual health,
health access and utilization, and premature death rates. The results indicate positive,
but small improvements due to the policy, with the only statistically signiﬁcant results
being two measurements of individual health.

Acknowledgments
I would like to thank a few individuals who’ve made this paper possible. Firstly my
mother Janet who was never unavailable to aid in even the oddest of situations and my
family who had no doubts about my ability to succeed. To my boyfriend Calvin who’s
company and kindness provided a well needed respite from the chaos of graduate
school. A thank you to my advisor Kat Bilicka whose trust in my abilities kept me going;
and to all the folks at the Center of Growth and Opportunity who gave me the chance
and the skills to complete my degree. A special thanks to my medical team who’s
sincerity and eﬀorts ensured that my body did not hold back my mind. And for my cat
Gillis, whose constant upkeep and warm cuddles ensured I did something other than
homework.

Table of Contents
Title Page

1

Abstract

2

Acknowledgments

3

Table of Contents

4

Introduction and Literature Review

5

Policy Description

8

History

8

Medicaid Expansion and the ACA

10

Critical Reception

11

Data and Analysis
Data Sources

13
13

Outcome Variables

13

Control Variables

15

Selecting Sample States

18

Empirical Methodology

20

Assumptions
Results and Conclusion

20
23

Descriptive Results

23

County Level Results

27

State Level Results

30

Conclusion

31

References

35

Appendices

41

Appendix I

41

Appendix II

43

Appendix III

45

Appendix IV

48

Appendix V

49

Appendix VI

53

Introduction and Literature Review
Since the ﬁrst federal proposal nationalized healthcare in the early 20th century,
healthcare has been a hot button issue in national politics. Of the various government
subsidized health programs, Medicaid represents $1 for every $6 spent on healthcare
in the United States (Rudowitz et al., 2021). With the onset of the COVID-19 pandemic,
healthcare access is all the more important. However, the question of eﬀectiveness is
always lingering. Does an increase in billions of dollars of spending eﬀectively improve
outcomes? In 2019, the expansion of medicaid cost $93.8 billion, making it one of the
most expensive expansions in healthcare of the century (Rudowitz et al., 2021). In
order to understand if this program is cost eﬀective, in this paper, I utilize a natural
experiment between states that did and didn’t expand to investigate the eﬀectiveness
of Medicaid expansion on health outcomes.
Utilizing data from the Behavioral Risk Factor Surveillance System (BRFSS), the
US Census Bureau, The Center for Disease Control and others, I apply a
diﬀerence-in-diﬀerences methodology to evaluate the eﬀect of Medicaid expansion on
various health outcomes. I use time and both state and county level variation in the
analysis. The treatment group are speciﬁcally selected states that expanded Medicare
in 2014 with the control being states that have not expanded medicaid at any point.
The groups were chosen based on geographic proximity, but have similar per capita
incomes, homeownership rates, poverty levels, as well as other metrics (see Table 1,

Appendix III). While results indicate a signiﬁcant diﬀerence in insurance cover,
individual health outcomes were small and frequently statistically insigniﬁcant.
The literature is overwhelming in its evidence that Medicaid expansion has
improved insurance coverage (Antonisse et al., 2017). Though research looking
speciﬁcally at medicaid expansion versus the Aﬀordable Care Act as a whole is limited.
Some research has found improvements in coverage and utilization (Gray et al., 2016;
Shartzer et al., 2016), Other research shows health and utilization outcomes without
statistically signiﬁcant results (Wherry & Miller, 2016). Despite increases in access,
work by other researchers have found no statistically signiﬁcant results in individual
health outcomes between expansion and non expansion states (Sommers et al., 2015).
Work by individuals at the Commonwealth Fund found that healthcare access and
individual satisfaction with Medicaid rivaled that of private insurers in self reported data
(Collins et al., 2016). There’s also evidence that ﬁnancial outcomes also improved. An
NBER working paper has found that medical debt collection and unpaid bills
decreased among those who gained Medicaid coverage (Hu et al., 2018). Other
research found that while problems paying for family medical bills decreased, unmet
needs for care due to cost had statistically insigniﬁcant results (Shartzer et al., 2016).
Work from Simon, Soni and Cawley found that while some forms of preventative
care increased, there’s no evidence that risky health behaviors such as smoking and
drinking increased in response to the expansion. They also found positive results in
their self reported health metrics which utilizes the same variables as this paper. A

notable diﬀerence between their approach and this paper is my usage of county level
data as well as variables and data sources beyond the BRFSS (Simon et al., 2016).
However, other research is generally isolated to speciﬁc conditions or branches
of healthcare. Looking speciﬁcally at dental care, research indicates that while
coverage did increase, there’s no evidence that usage improved (Nasseh & Vujicic,
2016). Regarding diabetes there’s solid evidence that the policy change led to an
increase in diabetes diagnosis, which is a good indicator of access and utilization
(Kaufman et al., 2015).
Other metrics of interest include preventable hospitalizations and premature
death. Using data from 2009- 2015 found signiﬁcant reductions in preventable
hospitalizations for some conditions such as chronic respiratory conditions, diabetes,
and bacterial pneumonia. Other conditions did not show such signiﬁcant changes.
(Wen et al., 2019). Research suggests that the policy has saved the lives of at least
19,200 adults 55-64 years old from 2014-2017. For states who did not expand, an
estimated 15,600 adults died prematurely. There’s an estimated 39-64% reduction in
annual mortality rate for older adults gaining coverage (Broaddus & Aron-Dine, 2019).
Using county level data, Borgschulte and Vogler found a 3.6 percent decrease in
mortality for ages 20-64 (Borgschulte & Vogler, 2020).

Policy Description
History
The earliest involvement of the US federal government in healthcare was the
establishment of 40 hospitals in the antebellum south as part of reconstruction. With
the rise of progressivism and populism in the early 20th century, national healthcare
reform and other social welfare programs became more commonplace in developed
countries. For example, in 1911 the United Kingdom passed the Nation Insurance Act
which would later become the National Health Service in 1948. The earliest eﬀorts
toward universal health coverage were led by Theodore Roosevelt, these eﬀorts were
only later realized when Franklin Delanor Roosevelt included publicly funded healthcare
programs as part of his New Deal legislation. Later, Harry S. Truman proposed
universal health care legislation which failed to pass due in part to opposition from
national medical groups (Manchikanti et al., 2017a).
The biggest reform of the 20th century came with the creation of Medicaid and
Medicare through the Social Security Amendments of 1965. This legislation was
spearheaded and signed into law by Lyndon B. Johnson. Within the ﬁrst three years
nearly 20 million individuals enrolled. Coverage included up to 90 days of hospital care
and 100 days each of nursing home care and home health care visits (Patel &
Rushefsky, 2019). Over the next decades, more reforms were proposed including a call
for nationalized health insurance and employer mandated health insurance, though

criticisms of cost led to their failure. The next successful change was the Consolidated
Omnibus Budget Reconciliation Act (COBRA) of 1985 which allowed employees to
continue with their group health insurance for a limited time after their employment had
ended. The next push for reform occurred during the Clinton administration headed by
The First Lady and future presidential candidate Hillary Clinton. However, their only
success came with the passage of the State Children’s Health Insurance program
(SCHIP) which provided health insurance coverage for uninsured children who didn’t
qualify for medicaid. Under George W. Bush the Medicare Modernization Act passed
which expanded coverage of prescription medication for medicare recipients
(Manchikanti et al., 2017b).
Arguably the biggest healthcare overhaul of this century has been with the
passage of the Aﬀordable Care Act under the Obama Administration in 2010. The 2006
Massachusetts expansion of health coverage, often called Romneycare after the then
governor Mitt Romney, acted as a blueprint for the ACA. The three primary goals of the
ACA were to increase the number of insured individuals, improve the quality of care,
and reduce the costs of healthcare overall. The ACA is credited with increasing the
number of insured by over 20 million, though an estimated 6 million lost their insurance
due to regulatory changes. The majority of this increase can be credited to Medicaid
expansion (Manchikanti et al., 2017a).

Medicaid Expansion and the ACA
Medicaid, as it exists now, is a state and federal partnership that provides health
insurance for low-income individuals, including children, parents, the elderly, and some
with disabilities. Before Medicaid expansion, the qualifying population for medicaid
was: pregnant individuals and children 18 and under in families earning below 138% of
the federal poverty line, some low income parents or caretakers, and most seniors and
disabled individuals who receive Supplemental Security Income (SSI). States may also
receive additional funding to cover “optional” populations, this include: some
individuals in the previous groups who earn more than 138% of the federal poverty line,
seniors and disabled individuals not receiving SSI but with income below the poverty
line, “medically needy” individuals with higher than qualifying incomes that have high
medical expenses that reduce their disposable income, and others with higher incomes
that need long term support. With the implementation of the ACA, states also have the
ability to cover all non-disabled adults with income below 138% of the federal poverty
line (Policy Basics, 2020).
Just as there is a mandatory and optional population to cover, the same exists
for beneﬁts provided. Some of the mandatory beneﬁts include in and outpatient
hospital services, physician care, home health, laboratory and x-ray services, family
planning, pediatric care, birth center and midwife services, EPSDT (Early and Periodic
Screening, Diagnostic and Treatment), as well as nursing facility access. Optional
beneﬁts include prescription drugs, physical/occupational therapy, specialized care

(podiatry, dental, optometry, speech and hearing services, ect), hospice, and private
nursing services among others (Mandatory & Optional Medicaid Beneﬁts | Medicaid,
n.d.).
In the years after the ACA’s passage, numerous legal challenges were brought
against it. Most notably National Federation of Independent Business v. Sebelius which
made it to the Supreme Court on appeal as California v. Texas. The Supreme Court
upheld all the provisions of the ACA but made Medicaid expansion essentially optional
for states (ACA Survives Legal Challenge, Protecting Coverage for Tens of Millions,
n.d.). As of April 2022, 39 states as well as Washington D.C. have adopted Medicaid
expansion while 12 have not (Status of State Medicaid Expansion Decisions, 2022).

Critical Reception
The success of Medicaid expansion for health outcomes has been
overwhelmingly positive. Additional research focused on speciﬁc conditions and
diseases. A meta analysis conducted by the Kaiser Family Foundation found that a
body of research indicates an increase in coverage for cancer patients as well as better
access to screenings and preventative care, however results on improved survival
outcomes are mixed. For individuals with diabetes, studies found increases in
coverage and aﬀordability of healthcare; though there are mixed results on the
utilization of preventative care as well as changes in the prevalence of diabetes overall.
Expansion signiﬁcantly increased maternal health and access with no deﬁnitive results
on fetal and infant health (Guth & Ammula, 2021) .

A source of signiﬁcant criticism of the ACA is the cost. According to Manchikanti
et al., healthcare exchange enrollment has been lackluster to the tune of 10 million
fewer enrollees than projected; while the number of individuals covered by private
insurance is steadily decreasing. The increasing price of insurance premiums and care
has put a burden on consumers while those on Medicaid are restricted by limited
provider networks. Not to mention the estimated 6 million individuals who lost their
health insurance entirely. Essentially, the ACA improved conditions for the poor through
medicaid expansion but worsened conditions for the middle class despite the
implementation of the Insurance Exchange Networks. While coverage has increased
overall, access and quality of care has not. As federal funding for medicaid expansion
phases out, state legislatures are grappling with the need to cover the cost as criticism
continues to grow (Manchikanti et al., 2017a).

Data and Analysis
Data Sources
Outcome Variables
Given the complexity of health as a measurement, this paper will cover a variety
of diﬀerent health metrics sourced from primarily survey data. The ﬁrst outcome
variable of interest is the rate of individuals without health insurance. Medicaid
expansion is all about providing Medicaid health insurance to more people so they can
more easily, and aﬀordably, access healthcare. County level data on health insurance
rate estimates come from The Small Area Health Insurance Estimates (SAHIE) Program.
This program was created in order to develop estimates of health insurance coverage
at the county and state level. It builds on the work of the Small Area Income and
Poverty Estimates (SAIPE) program. The data includes race/ethnicity, sex, age, and
income indicators. The program models health insurance coverage using The American
Community Survey (ACS), demographic estimates, federal tax returns, Supplemental
Nutrition Assistance Program (SNAP) participation, business patterns, Medicaid,
Children’s Health Insurance Program (CHIP) participation and census data (Bureau,
n.d.-a).
Other outcomes of interest are percent of adults in poor or fair health, number of
physically unhealthy days, and number of mentally unhealthy days. The latter two are
counts in the past 30 days. Data for these metrics was sourced from the Behavioral

Risk Factor Surveillance System (BRFSS). The BRFSS is a national random digit dial
(RDD) telephone survey which completes more than 400,000 adult interviews each
year. The survey covers information regarding health related risk behaviors, chronic
health conditions, and use of preventative services (CDC - About BRFSS, 2014).
Other metrics of use for outcomes are exclusively state level. The preventable
hospitalizations variable is a count of discharges following hospitalization for
ambulatory-care sensitive conditions per 100,000 Medicare beneﬁciaries ages 18 and
older enrolled in the fee-for-service program. Conditions considered ambulatory-care
sensitive in the calculation are diabetes complications, chronic obstructive pulmonary
disease (COPD), hypertension, heart failure, dehydration, bacterial pneumonia, urinary
tract infections, angina and young adult asthma (AHRQ QITM Version 4.5, Prevention
Quality Indicators #90, Technical Speciﬁcations, Prevention Quality Overall Composite,
2013). This data comes from The Dartmouth Atlas of Health Care (Dartmouth Atlas of
Healthcare, 2019). The next variable is premature death which is the years of potential
life lost before age 75, per 100,000 people. The data came from the CDC multiple
causes of death data ﬁles (Multiple Cause of Death Data on CDC WONDER, n.d.). The
last metric is the percent of adults who reported a time in the past 12 months when
they needed to see a doctor but could not because of cost. This data came from the
BRFSS. All state level data utilized was collected via America’s Health Rankings
(America’s Health Rankings | AHR, n.d.).

Control Variables
Since the identiﬁcation strategy is a natural experiment, it's important to
understand where the two groups diﬀer as those factors may impact healthcare
outcomes outside of Medicaid expansion. The primary variables of interest are percent
of population that is Black or African American, percent of population that is rural, as
well as obesity and smoking rates. Comparisons for other variables are displayed in
Table 1, Appendix III.
Health behaviors contribute signiﬁcantly to individual health. Two measurements
popular in the literature are smoking and obesity rates. Smoking causes diabetes,
stroke, various forms of cancer and many cardiovascular diseases such as heart and
lung disease, COPD, emphysema, and chronic bronchitis among others. It also puts
individuals at increased risk for Tuberculosis, certain eye diseases, and immune
dysfunction such as rheumatoid arthritis. Secondhand smoke exposure contributes to
an estimated 41,000 deaths of nonsmoking adults and 400 infant deaths each year. For
children, second hand smoke puts them at risk for sudden infant death syndrome,
acute respiratory infections, middle ear disease, worsening asthma, and slower lung
growth (CDCTobaccoFree, 2022). Medicaid covers a number of diﬀerent treatment
options for those struggling from addiction, including emergency intervention, in and
out patient rehab services, counseling, addiction treatment medication, and medical
detoxes (DiGiulio et al., 2016). Not only do these treatments help individuals who
smoke with the negative health consequences, the fewer people who smoke the less

second hand smoke that can damage other people’s health. Which improves the
overall health of the community.
Obesity is associated with a number of diﬀerent chronic conditions such as type
II diabetes, asthma, chronic pain, mental health conditions, cardiovascular diseases,
and various forms of cancer (Djalalinia et al., 2015; Sarwer & Polonsky, 2016). Despite
the impressions of popular culture, much of obesity is genetic. Research from Ruth
Mcphersen out of the University of Ottawa found that heritability of obesity is between
40-70% (McPherson, 2007) with other estimates as high as 84% (Stunkard et al.,
1986). Unsurprisingly, long term weight loss from lifestyle changes alone tends to fail,
independent of individual willpower (Mann, 2018). For these reasons, it’s important to
view obesity not as a risky health behavior but rather as an indicator of chronic illness
in a population. Chronic illnesses eat up an estimated 86% of US healthcare costs
(Holman, 2020). Meaning that medicaid expansion could have a signiﬁcant impact on
the quality of life within populations with high rates of obesity.
State and county level data on smoking and adult obesity rates was sourced
from the CDC Diabetes Interactive Atlas which includes county level estimates for
obesity, physical activity and diabetes. These estimates are calculated using 3 year
estimates from the aforementioned BRFSS and population measures from the U.S.
Census Bureau’s Population Estimates Program (Kirtland et al., 2014).
Another factor to consider is the size of the rural population. Rural populations
are consistently found to be older, sicker, and poorer than urban populations. Rural

areas also have more limited access to health care. In 2013, there were 79.3 primary
care physicians per 100,000 people in non-rural counties, compared to only 55.1 per
100,000 people in rural counties (Clawar et al., 2018). Fortunately, the availability of
telehealth and other innovations in healthcare help close that gap and improve health
outcomes for rural Americans (Butzner & Cuﬀee, 2021). Healthcare accessibility plays
an important role in the eﬃcacy of medical insurance expansion policies. Having
medical insurance isn’t especially meaningful if there are no physicians available either
due to distance or short supply. Year 2017 was excluded from the rural population
data, again due to data accuracy concerns.
County and State level population estimates for race/ethnicity and rural
populations come from the US Census Bureau's population estimates survey. State
level race data is speciﬁcally sourced from the Annual State Resident Population
Estimates for 6 Race Groups (5 Race Alone Groups and Two or More Races) by Age,
Sex, and Hispanic Origin data set (Bureau, n.d.-b). Racial diﬀerences are particularly
important given that Black populations are the most economically disadvantaged
minority group and have consistently worse healthcare outcomes than their White
counterparts. Due to these factors, the Aﬀordable Care Act made a signiﬁcant impact
on healthcare coverage for these individuals (Taylor, 2019).
The county level data was gathered through the County Health Rankings &
Roadmaps (CHR&R) as part of the University of Wisconsin Population Health Institute.

The analysis utilizes county level data for years 2011 - 2018 excluding 2015 and 2019
for the outcome variables and 2017 due to data accuracy concerns.

Selecting Sample States
Due to the legal challenges to the ACA, medicaid expansion was an opt-in
program for states. Thus, some states had a later or atypical implementation while
others did not expand at all. The following graphic illustrates which states chose what
approach.

21 of the 50 states implemented medicaid expansion in 2014 while 12 states
have not expanded. The remaining 17 states either expanded after 2014 or expanded
with additional provisions or state speciﬁc structures. Examples include Missouri's
work requirement for Medicaid enrollees and Arkansas’s partnership with private
insurers (Status of State Medicaid Expansion Decisions, 2022). Those 17 states will not

be utilized in the analysis. Leaving 33 states for potential analysis. Of the states that
didn’t expand, all but Texas will act as the control group. Texas isn’t included due to
the sheer size, high hispanic and rural populations that can’t be accurately
counterbalanced by the available treatment states. The treatment states were chosen
primarily based on geography while keeping in mind population demographics. One
notable exception is Nevada. Nevada was chosen over Colorado since Nevada has a
higher rural and non white population than Colorado making it a better match for the
control states. The non-expanding states are primarily in the south which has some of
the highest Black populations in the country. East coast states such as Maryland and
Delaware were included due to their relatively high Black populations. The following is
a map showing which states will be used for the analysis.

Empirical Methodology
A controlled experiment is the only way to determine causality of a treatment.
Few economic policies can be replicated in a lab so one must utilize causal inference
statistical methods to study causality. One such method is a diﬀerence-in-diﬀerences,
a quasi-experimental identiﬁcation strategy. Diﬀerence-in-diﬀerences is a natural
experiment where exposure to treatment and control conditions occurs without exterior
intervention. Speciﬁcally, this analysis uses a 2x2 DD design with areas of interest with
and without treatment and a time period before and after treatment (Cunningham,
2021, Ch. 9).
For each of our outcome variables, we estimate the following DD regression:

Where 𝑌 represents the outcome variable of interest. The binary dummy variables are
𝑇𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡𝑔 which equals 1 if the group of 𝑔 states or counties has expanded Medicaid
while 𝑃𝑜𝑠𝑡𝑡 equals 1 at time 𝑡 is after the treatment went into eﬀect, in this case the
year is 2014. γ𝑋𝑔𝑡 represents the control variables, in this case obesity rate, smoking
rate, and percent of the population that is Black.

Assumptions
Assumptions are an important requirement to insure the validity of a model. The
ﬁrst assumption one must meet for a diﬀerence-in-diﬀerences is that the intervention
implementation is unrelated to the health outcome. Medicaid did not expand in areas

with worse health outcomes. On the contrary, the non expanding group had markedly
worse health outcomes than expanding states. The decision to expand occured
strongly along party lines with conservative states less likely to expand while liberal
states were more likely to expand. The next assumption is that the treatment and
control groups are comparable. While it’s nearly impossible to guarantee that all
characteristics are equal in two naturally occurring groups, group averages in Table 1,
Appendix V indicate that economic, wealth, and housing metrics are suﬃciently similar.
The most critical assumption to meet in a Diﬀerence-in-Diﬀerences model is the
parallel trends assumption. This assumption requires that the trend illustrated in each
group without the treatment is parallel and that the trend in the control group remains
constant before and after the treatment. The best way to see if the assumption is met
is by visualizing the data (Cunningham, 2021, Ch. 9). Graphical displays are available in
Appendix V. Given the volatility of the data, it’s diﬃcult to say whether the trends in the
control group are consistent across the given time period. However, the initial parallel
trend is still clear.
The percent uninsured metric shows an increase from 2011 to 2013 with a slight
decrease into 2014. The values are nearly perfectly parallel so the assumption is clearly
met. For the poor or fair health measurement, both groups are decreasing from
2011-2013 and then increase to 2014. While they are not perfectly parallel they are
suﬃcient for this assumption. The number of healthy days metric shows nearly
constant values in both from 2011 to 2013 with a sharp increase to 2014. While there’s

signiﬁcant narrowing between the groups from 2013-2014, the assumption is still
suﬃciently met. Of the previously mentioned variables, the mentally unhealthy days
metric best meets the assumption. The groups are parallel and increasing 2011-2012
and 2013-2014 but decreasing from 2012- 2013. The trends are nearly perfectly
parallel so the assumption is met.
For the state level data, preventable hospitalizations data does not meet the
assumption since the non-expanding group average is higher than the expanding
group for 2011 exclusively. Meaning the lines intersect and aren’t parallel. The
premature death metric shows a slight decrease in results from 2011-2013 for the
non-expanding but an increase then decrease for the expanding group. While both
groups increase between 2013-2014 this isn’t suﬃcient to meet the assumption. For
the avoiding care metric. Both groups have decreasing values from 2012-2014.
However, since the non-expanding stats increase from 2011-2012 while the other
states decrease the assumption is not met.

Results and Conclusion
Descriptive Results
The uninsured adults metric shows a median percent in the non-expanded
states of around 10 percentage points higher than the expanded states. There's also a
clear decrease for both groups from 2014 onward. Graphical display of this data can
be found in Appendix I as Figure 1. This variable has 13839 data points indicating no
missing data with a mean of 18.569 and a standard deviation of 6.398 which indicates
a relatively wide spread in the data. The mean and standard deviation both decrease
after winsorization. Summary statistics are available in Appendix IV.
The other county level outcome variables of interest are percentage of
population in poor or fair health and number of mentally/physically unhealthy days.
These metrics include nearly 400 missing data points. Box and whisker plots for each
are available in the Appendix I as Figures 2, 3, and 4. The plot for percent of those in
poor or fair health shows that the median non-expanding states are consistently a few
percentage points higher than the expanding states but the values remain between
15-20% over the given time period. There’s also numerous outliers in the upper range
of the data. Before winsorization, this variable’s average is 17.749 with standard
deviation of 5.707; decreasing slightly after winsoration. Again, the standard deviation
indicates a wide spread in the data but not quite as wide as the uninsured metric.

Both poor physical and mental health are measured as the number of days out
of the last 30. Again, each is missing around 400 data points. The graphic shows that
the non expanded group median is slightly higher than the expanded group which
remains relatively constant over the time period. The mean is 3.946 with a standard
deviation of 1.041 which changes to 3.922 and 0.891 after winsorization. In contrast,
the mentally unhealthy days mentric, has the expanded group median as slightly higher
for 2011-2014 but slightly lower after 2014. The average is slightly lower at 3.704,
3.697 after winsorization, and the standard deviation of 0.915 is also lower and lower
still after winsorization. Additionally, there are a signiﬁcant number of outliers for both
day count variables, indicating large variation in the data, particularly in years
2011-2014. Fully summary statistics are available in Appendix IV.
The state level data overall shows fewer outliers than the county level data. The
graphic of the preventable hospitalization metric (see Appendix II, Figure 1) shows that
the median for not expanded states is generally higher than the expanded states. The
range however, is much higher for the expanding states. There’s a decreasing trend
overall for both groups. The average for this metric is 60.533 with a standard deviation
of 15.233 which decreases slightly after winsorization. This metric has only 12 missing
data points. The premature death metric, measured as years of potential life lost, has
an average value of 8175.085 and standard deviation of 1414, indicating a smaller
spread than the previous variable. The graphic Figure 2 in Appendix II shows that the
median value for the expanded group is higher than the non-expanding group for all

years but 2014 and 2015. The range of data is similar for both and there is a slight
increasing trend over time. The ﬁnal metric is percent of individuals who avoided
healthcare due to cost. The average value is 14.344% with a standard deviation of
3.727 which is almost identical to the winsorized version of this variation. The
non-expanding group has a consistently higher value than the expanding group with
both groups having similar ranges. There’s also a trend of decreasing values from
2011-2015 which remains relatively constant to 2019, viewable in Appendix II as ﬁgure
3.
Among our controls, the most concerning potential diﬀerence between the two
groups is the Black or African American population. As illustrated by ﬁgure 1 in
Appendix III, not only does the control group have a signiﬁcantly higher Black
population than the treatment group but the increase in population is also higher for the
control group. The African American population estimate is slightly higher than the
county level estimate though both standard deviations are extremely high. The rural
population average is 61% indicating that over half of our data is from rural areas. The
standard deviation is 29.927, both values nearly equal with their winsorization. Figure 2
in Appendix III illustrates that the non expanded group is more rural than the expanded
group. With a notable exception of 2018, the change in rural population is similar
between the two groups. Since the spike from 2018 is only for a few percentage points
it isn’t necessary to include this data as a control.

Figure 3 in Appendix III illustrates smoking rates by treatment group. Looking at
the median value, the expanded states appear to have a slightly higher smoking rate.
However, the range within states is as high as 40 percentage points but decreases
around 2016. In addition to numerous outliers throughout. Meaning there’s a high
variation between states, even within the same treatment group. The smoking rate for
both states and counties averages around 20 with a standard deviation higher at 5.24
for county level data. All values similar to their winsorizations. From Figure 4 in
Appendix III, it appears that, at the median, the non expanding states have an obesity
rate a few percent higher than the expanding states. However, the range is again very
high with a large number of outliers. Indicating high levels of variation within treatment
groups. The obesity rate average is approximately 30 for both geographic
measurements with a standard deviation slightly higher in the county level data with a
value of 4.032 before winsorization. Again, winsorization had little impact on the
variables.
Since the analysis is based on mean values, the volume of outliers is concerning
given that averages tend to be sensitive to extreme values. In order to account for this,
the analysis will utilize winsorized versions of each variable. Winsorizing data means
that a predeﬁned quantum of the smallest and/largest values, in this case the top and
bottom 5%, are replaced by less extreme values. This calculation was done through
the DescTools package in R (Signorell et al., 2022). Summary statistics for all variables
are available in Appendix IV.

County Level Results
The regression results from the analysis are displayed below:

The main variables of interest in the model are the control variables and the interaction
term which is the indicator for the policy change. The ﬁrst regression describes the
relationship of our variables with the percent of the population that’s uninsured. The

African American population and Smoking Rate variables are both positive with
coeﬃcients of 0.099 and 0.519 respectively. Indicating that the model estimates that an
increase in either corresponds to an increase in the percent uninsured. Both
coeﬃcients lie within exclusively positive conﬁdence intervals, making the
interpretation even more reliable. The obesity rate coeﬃcient is negative meaning that
the model estimates that an increase in obesity rates decreases the percent uninsured.
A potential explanation is that the lack of mobility caused by obesity can qualify
individuals for Social Security Disability Beneﬁts which gives individuals health
insurance access (“SSR 19-2p: Titles II and XVI: Evaluating Cases Involving Obesity,”
2019). As anticipated by previous research, the coeﬃcient for the interaction term is
negative indicating that the percent of uninsured 1.612% lower in states that expanded
medicaid than those that didn’t. The result is promising as expanding insurance access
was the main purpose of expanding medicaid. Further details on the regression are in
Table 1, Appendix VI
For the percent in poor or fair health metric, the three control variables are
positive and have standard deviations of positive values as well. Indicating that
increases in any of those values also increase the population in poor or fair health. This
is expected as each of these variables is associated with poor health outcomes. The
controls are also statistically signiﬁcant at a 99% conﬁdence level. The interaction term
coeﬃcient is -0.139 indicating that the states which expanded have an estimated
population in poor or fair health 0.139 percentage points lower than states that didn’t

expand. The p-value for this coeﬃcient is 0.367 meaning it is not statistically
signiﬁcant. However, when the regression includes just Black population and obesity as
controls the coeﬃcient is statistically signiﬁcant at a 95% conﬁdence level. Similarly, if
the regression doesn’t include percent of African Americans, but includes all other
variables, the coeﬃcient is statistically signiﬁcant at a 90% conﬁdence level. These
results are displayed in Table 2, Appendix VI. Despite this, the negative coeﬃcients ﬁt
with the intention of the policy change which indicates the policy may be objectively
eﬀective in other areas.
The last two regressions for the count of physically unhealthy days and mentally
unhealthy days, displayed as Table 3 and 4 in Appendix VI. Again, the three control
variables for each regression are positive, indicating that increases in any of those
values also increase the number of mentally and physically unhealthy days. This is
naturally expected as each of these variables is associated with poor health outcomes.
The interaction coeﬃcient for the count of physically unhealthy days is -.085 and the
interaction coeﬃcient for the count of mentally unhealthy days is -.16. Both of which
are statistically signiﬁcant at a 99% conﬁdence level. While the values may seem
inconsequentially small, they represent very real experiences. These values represent a
diﬀerence of 1.03 and 1.95 healthy days a year. Which over a lifetime can be incredibly
2

meaningful. The 𝑅 for these regressions is .49 and .41, indicating that nearly half of the
variation in these health metrics can be explained by relatively few variables.

State Level Results
Since none of the state level metrics met the parallel trends assumption, it’s
important to take this into account when viewing the regression results. Output from
those regressions are displayed below.

With the exception of the obesity measurement in regression 3, all the control variables
are statistically signiﬁcant at a 99% conﬁdence level. The coeﬃcients for the control

variables are also all positive which is what one would logically expect from the data.
The interaction terms for preventable hospitalizations and avoiding care due to cost are
negative which indicates a beneﬁcial impact of the policy. In contrast, the coeﬃcient
for premature death is positive, suggesting that medicaid expansion worsened
premature deaths. Regression 1 estimates a decrease in preventable hospitalizations of
0.611 per 1,000 individuals. Regression 2 estimates an increase in premature death of
.049 years per 100,000 individuals. While regression 3 estimates a decrease in percent
of individuals who avoided care due to cost of 0.666%. Not only are these results
statistically insigniﬁcant, the values are small enough to be of little practical
2

signiﬁcance. However, the models have adjusted 𝑅 value of 0.76, 0.651, and 0.496
respectively. Indicating that a relatively high percentage of the variation in the input
metrics explain the variation in output variables, particularly the control variables.

Conclusion
The population who gained medicaid under the expansion cost $93.8 billion in
2019. That comes to around $6,000 per individual per year (Guth et al., 2021). For a
policy this expensive it’s important to investigate whether the results are worth the
cost. Utilizing a diﬀerence-in-diﬀerences modeling technique, this paper addresses the
relationship between medicaid expansion and various health outcomes. The outcome
metrics were percent of individuals in poor or fair health, number of mentally unhealthy
days in the last 30 and number of physically unhealthy days in the last 30. All using

data gathered at the county level. For the state level data, the metrics of interest were
counts of preventable hospitalizations, years of life lost due to premature death, and
percent of individuals who avoided care due to cost. The models also utilized control
variables measuring the African American population, smoking rates, and obesity rates.
Of these metrics, the only outcome measurements that were statistically signiﬁcant
were the physically and mentally unhealthy days metrics, while all the control variables
were consistently statistically signiﬁcant. Overall the results were lackluster for a
sweeping policy change like Medicaid Expansion.
A particular point of interest is that the model showed a less than 1% decrease
in those who avoided care due to cost, which was not statistically signiﬁcant. Why
didn’t an increase in healthcare coverage have a bigger impact on healthcare
participation for the poor? One potential explanation is that enrollment still isn’t high
enough to see an impact yet. More than a quarter of nonelderly uninsured individuals
qualify for medicaid or CHIP (Children’s Health Insurance Program). This comes to
around 7 million individuals (Orgera & Rudowits, 2021). If these individuals frequently
experience poor health, perhaps their lack of coverage is what's driving these results.
Another element to consider is the diﬃculty of ﬁnding physicians, even in
metropolitan areas. A recent paper from the National Bureau of economic research
found that the administrative costs of billing medicaid lead to a 17% loss in revenue,
compared to 5% or less from medicare and private insurers (Dunn et al., 2021). Health
insurance doesn’t mean much if you have nowhere to use it. Instead of focusing on

increasing coverage, perhaps policymakers should focus on ensuring that the
coverage available is eﬀective and eﬃcient for individuals and clinicians.
Notably, the model results consistently show markedly poorer health outcomes
for smokers, the obese, and African American populations. Further policy work should
focus on how to improve health outcomes for these individuals. The medical
establishment has a long history of mistreating minority populations, including forced
sterilization and withholding treatment. The African American community has been
particularly vulnerable to these experiences. Research shows that Black patients are
consistently undertreated for pain compared to White patients and that medical
professionals frequently misjudge the impacts of police brutality, poverty, and other
commonplace experience of minority groups. One study found that half of medical
students and residents held false beliefs about the biological diﬀerences between
Black and White patients. It’s no surprise that this kind of treatment has led to less use
of medical care and a marked mistrust of the medical system. This is manifested most
recently in lower COVID-19 vaccination rates in these populations (Hostetter & Klein,
2021).
Similarly, weight based discrimination can have a major impact on whether one
utilizes healthcare services. Research shows that doctors are the second most
common source of weight based stigma, and over half a sample of overweight
individuals reported inappropriate comments from medical providers about their
weight. Other research has found that doctors frequently think worse of their obese

and overweight patients and were less willing to help them than their thinner patients
(Schvey, 2010). Aggreate health outcomes cannot improve until systematic
discrimination is addressed head on.
Ultimately, my analysis indicates that while there’s some veriﬁable
improvements, there’s too many unknowns to determine whether this policy was a
success. Healthcare and policy research needs more innovative ways to measure
policy success, beyond survey data and self reported statistics. The Aﬀordable Care
Act was a massive change to US healthcare which will require an extensive body of
literature to understand proﬁciently. Simply put, there is more work to be done.
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